NCT03690180

Brief Summary

To find if there is a corrolatation between Microalbuminurea and diabetic retinopathy, in daibetic patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2018

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 31, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

October 1, 2018

Completed
Last Updated

September 10, 2019

Status Verified

September 1, 2019

Enrollment Period

29 days

First QC Date

March 31, 2018

Last Update Submit

September 6, 2019

Conditions

Diabetic Nephropathies

Outcome Measures

Primary Outcomes (1)

  • Decrease in serum magnesium

    statistical significant change in serum magnesium in diabetics with microalbuminuria

    One month

Study Arms (2)

Diabetics with microalbuminuria

Diabetics with micro albuminuria will be subjected to full clinical examination. Measurement of weight, height, waist, hip and calculation of BMI and waist hip ratio,laboratory assessment of serum creatinine,HbA1C,magnesium and urinary albumin creatinine ratio

Diagnostic Test: serum magnesium

Diabetics with normal albuminuria

Diabetics with micro albuminuria will be subjected to full clinical examination. Measurement of weight, height, waist, hip and calculation of BMI and waist hip ratio,laboratory assessment of serum creatinine,HbA1C,magnesium and urinary albumin creatinine ratio

Diagnostic Test: serum magnesium

Interventions

serum magnesiumDIAGNOSTIC_TEST

assessment of serum magnesium in all patients

Diabetics with microalbuminuriaDiabetics with normal albuminuria

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Diabetic patients following up in out patient clinic of diabetes and endocrine ,Fayoum university Hospital

You may qualify if:

  • Diabetics on oral treatment,diabetics on insulin

You may not qualify if:

  • Healthy volunteers,,hypertensive patients with normal blood glucose

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine Fayoum univesity

Al Fayyum, Egypt

Location

MeSH Terms

Conditions

Diabetic Nephropathies

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Medicine,Faculty of Medicine,Fayoum university

Study Record Dates

First Submitted

March 31, 2018

First Posted

October 1, 2018

Study Start

January 1, 2018

Primary Completion

January 30, 2018

Study Completion

February 28, 2018

Last Updated

September 10, 2019

Record last verified: 2019-09

Locations

EG(1)